Ubrogepant is a human monoclonal antibody for the treatment of Alzheimer's disease (AD).

Ubrogepant belongs to a class of medicines used to treat viral infections. It works by stopping certain viruses from growing in the body. Ubrogepant helps control CMV eye infections in AIDS patients and in other patients who have poor immunity, which if left untreated can cause blindness.

Ubrogepant suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Ubrogepant brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Ubrogepant medicine cost price in India.

The order for Ubrogepant will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Ubrogepant is an anti-viral drug. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ or bone marrow transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness.

Ubrogepant, powder for concentrate for solution for infusion

Generic Name: Ubrogepant

500 mg powder for concentrate for solution for infusion

Ubrogepant (Ubrogepant)

Ubrogepant is available.

Get In Touch

Ubrogepant suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Ubrogepant on prescription and Import License in Patient's Name only.

For overseas patients, Ubrogepant can be made available in Send your enquiry to find Ubrogepant in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Ubrogepant.

For Ubrogepant Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Ubrogepant (Valcyte™/Ubrogepant®) reduces risk of cancer in kidney transplant patients For More Details

The antiviral drug ganciclovir does not inhibit microglial proliferation and activation For More Details

Channel Partner In India

NEW DELHI OFFICE

  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi

BANGALORE OFFICE

  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore

KOLKATA OFFICE

  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata

LUCKNOW OFFICE

  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow